Credit rating agency, CARE has assigned ‘BB+’ rating to Mangalam Drugs & Organics’ Long-term bank facilities worth Rs 14 crore. The rating agency has also assigned ‘A4+’ rating to company’s Short-term Bank Facilities worth Rs 6 crore.
The ratings assigned to the bank facilities of Mangalam Drugs and Organics (MDOL) are constrained by its relatively small scale of operations in the Active Pharmaceutical Ingredients (APIs)/ Bulk Drugs Industry along with limited product offerings, client concentration risk and working capital-intensive nature of operations. The ratings also factor in MDOL’s low profitability margins and its susceptibility to foreign exchange fluctuation, volatile raw material prices as well as prevailing intense competition in the API/Bulk drugs industry
Mangalam Drugs & Organics is engaged in manufacturing of Active Pharmaceutical Ingredients APIs, Intermediates at VAPI, Gujarat.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: